In parallel to the proliferative deficits, the remaining CD34+ cells in the +AML groups adopted a more immature HSPC phenotype (CD34+CD38–) than CD34+ cells alone, indicating a potential differentiation defect (Figure 1E). The gene discussed is CD34; the disease is acute myeloid leukemia.